PROLIXIN
FLUPHENAZINE HYDROCHLORIDE
Approval overview PROLIXIN is listed in Drugs@FDA under application 012145 (NDA).
Marketing status: Discontinued Active ingredient FLUPHENAZINE HYDROCHLORIDE Form and strength ELIXIR;ORAL - 2.5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor APOTHECON Submission history Latest submission status date: 2007-12-07 00:00:00.
Structured Monograph
Clinical summary
Approval overview PROLIXIN is listed in Drugs@FDA under application 012145 (NDA). Marketing status: Discontinued Active ingredient FLUPHENAZINE HYDROCHLORIDE Form and strength ELIXIR;ORAL - 2.5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor APOTHECON Submission history Latest submission status date: 2007-12-07 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.